The G protein-coupled receptor heterodimer network (GPCR-HetNet) and its hub components by Borroto-Escuela, Dasiel O et al.
Int. J. Mol. Sci. 2014, 15, 8570-8590; doi:10.3390/ijms15058570 
 





The G Protein-Coupled Receptor Heterodimer Network  
(GPCR-HetNet) and Its Hub Components 
Dasiel O. Borroto-Escuela 1,†,*, Ismel Brito 1,2,†, Wilber Romero-Fernandez 1,  
Michael Di Palma 1,3, Julia Oflijan 4, Kamila Skieterska 5, Jolien Duchou 5,  
Kathleen Van Craenenbroeck 5, Diana Suárez-Boomgaard 6, Alicia Rivera 6,  
Diego Guidolin 7, Luigi F. Agnati 1 and Kjell Fuxe 1,* 
1 Department of Neuroscience, Karolinska Institutet, Retzius väg 8, 17177 Stockholm, Sweden;  
E-Mails: ismel@iiia.csic.es (I.B.); wromfdez@gmail.com (W.R.-F.);  
michael.dipalma@uniurb.it (M.D.P.); luigiagnati@tin.it (L.F.A.) 
2 IIIA-CSIC, Artificial Intelligence Research Institute, Spanish National Research Council,  
08193 Barcelona, Spain 
3 Department of Earth, Life and Environmental Sciences, Section of Physiology,  
Campus Scientifico Enrico Mattei, Urbino 61029, Italy 
4 Department of Physiology, Faculty of Medicine, University of Tartu, Tartu 50411, Estonia;  
E-Mail: juliaofli@gmail.com 
5 Laboratory of Eukaryotic Gene Expression and Signal Transduction (LEGEST), Ghent University, 
9000 Ghent, Belgium; E-Mails: kamila.skieterska@ugent.be (K.S.); jolien.duchou@ugent.be (J.D.); 
kathleen.vancraenenbroeck@ugent.be (K.V.C.) 
6 Department of Cell Biology, School of Science, University of Málaga, 29071 Málaga, Spain;  
E-Mails: boomgaard@uma.es (D.S.-B.); arivera@uma.es (A.R.) 
7 Department of Molecular Medicine, University of Padova, Padova 35121, Italy;  
E-Mail: diego.guidolin@unipd.it 
† These authors contributed equally to this work. 
* Authors to whom correspondence should be addressed;  
E-Mails: dasiel.borroto.escuela@ki.se (D.O.B.-E.); Kjell.Fuxe@ki.se (K.F.);  
Tel.: +46-852-487-077 (D.O.B.-E.); Fax: +46-8-315-721 (D.O.B.-E.). 
Received: 19 December 2013; in revised version: 26 March 2014 / Accepted: 30 April 2014 /  
Published: 14 May 2014 
 
Abstract: G protein-coupled receptors (GPCRs) oligomerization has emerged as a vital 
characteristic of receptor structure. Substantial experimental evidence supports the existence 
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of GPCR-GPCR interactions in a coordinated and cooperative manner. However, despite 
the current development of experimental techniques for large-scale detection of GPCR 
heteromers, in order to understand their connectivity it is necessary to develop novel tools 
to study the global heteroreceptor networks. To provide insight into the overall topology of 
the GPCR heteromers and identify key players, a collective interaction network was 
constructed. Experimental interaction data for each of the individual human GPCR 
protomers was obtained manually from the STRING and SCOPUS databases. The 
interaction data were used to build and analyze the network using Cytoscape software.  
The network was treated as undirected throughout the study. It is comprised of 156 nodes, 
260 edges and has a scale-free topology. Connectivity analysis reveals a significant 
dominance of intrafamily versus interfamily connections. Most of the receptors within the 
network are linked to each other by a small number of edges. DRD2, OPRM, ADRB2, 
AA2AR, AA1R, OPRK, OPRD and GHSR are identified as hubs. In a network 
representation 10 modules/clusters also appear as a highly interconnected group of nodes. 
Information on this GPCR network can improve our understanding of molecular 
integration. GPCR-HetNet has been implemented in Java and is freely available at 
http://www.iiia.csic.es/~ismel/GPCR-Nets/index.html. 
Keywords: G protein-coupled receptors; network; heterodimerization; heteromers; 
dimerization; oligomerization; hubs; receptor–receptor interactions; clusters; architecture 
 
1. Introduction 
A large number of cellular processes are mediated through physical protein-protein interactions. 
Protein association is implicated in cellular signal transduction, regulation of gene expression,  
post-translational modification, and in protein function. A huge variety of protein associations are 
multimeric in their biological active state [1]. Hence, extensive research was carried out to identify and 
to understand the underlying principles of protein association based on the postgenomic emerging 
concept that the cell must be viewed as complex networks of interacting biomolecules instead of 
individual cellular components with their own, specific functions [2–5]. 
Despite the seemingly vast differences among these cellular networks, they all share common 
features in terms of network topology. The topological analysis of large networks of biomolecule 
interactions has contributed to the functional prediction of biological and pharmacological propensities 
of novel genes or proteins [6–8]. However, several functions of proteins have yet to be fully elucidated 
or even predicted. 
Networks have proven to be a useful mathematical artifact for studying complex systems in 
multiple disciplines such as economics, sociology, and biology [2,6,8,9]. The term biological network 
refers to networks that describe relationships among a set of elements within biological systems. A 
network can be formally defined by a set of N elements and a set of R relations among those elements. 
A graph is a common way of visualizing networks. In a network graph, the nodes of the graph are the 
elements of the network and the edges correspond to the relations among the elements of the network. 
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Knowing the model of a biological network is essential to further understand the complex system that 
is modeled. To this aim we need to examine some topological features like, for example, the node 
degree distribution and the clustering coefficient. The most elementary topological feature of a 
network is the node degree, which measures the number of connections or links the node maintains 
with other nodes. Conversely, the analysis of the clustering coefficient assesses the trend of the nodes 
of the network to form clusters. 
One of the most unpredictable and confounding post-translational protein functions is the 
heterodimerization of G protein-coupled receptors (GPCRs). The description of a GPCR superfamily 
expanded considerably after the important discovery by Lefkowitz and colleagues in 1986 [10].  
A wide range of GPCRs was proven to function not only as homomers but also as heteromers [11–18]. 
In the past, interactions between receptors were regarded only as a result of interactions due to changes 
in membrane polarization or to changes in phosphorylation/dephosphorylation of receptors. However, 
our observations in the early 1980s emphasized the existence of direct receptor–receptor interactions in 
the plasma membrane between different types of GPCRs [19–22]. As a logical consequence of the 
indications of direct physical interactions between neuropeptide and monoamine receptors, we 
introduced the term heterodimerization in 1993 to describe a specific direct interaction between 
different types of GPCRs [23]. The concept of a GPCR heterodimer was later confirmed in 1998–1999 
by studies reporting that two non-functional GPCR monomers, GABAB1 and GABAB2, can assemble 
in a signaling heterodimer [24]. The GABAB receptor belongs to the class C GPCR with heterodimerization 
taking place between the Venus flytrap modules and the C-terminal coiled-coil domains [25–27].  
At the beginning of this century, a series of important contributions have confirmed the relevance of 
dimerization processes within the GPCR superfamily; special mention is the pioneering work of the 
Fuxe [28], Franco [29,30], Bouvier [31–33], Reynolds [34–36], Devi [37], Kenakin [38], George [39,40], 
Wess [41], Blumer [42], Bockaert [43] and Portoghese [44,45] groups, as some relevant examples. 
Allosteric mechanisms make possible the integrative activity intermolecularly via  
receptor–receptor interactions in GPCR homomers, heteromers and receptor mosaics (higher order 
oligomers) [11,13–16,46–51]. Receptor–receptor interactions markedly increase the repertoire of 
GPCR recognition, signalling and trafficking in receptor heteromers. The GPCR assemblies mentioned 
are not isolated but usually also directly interact with other proteins with which they form the 
horizontal molecular networks in the plasma membrane. 
Direct interactions involving GPCRs were demonstrated through diverse methods that assess 
receptor–receptor interactions [12,17,52–59]. In this study, we manually collect static/non-dynamical 
human GPCR data derived from these interaction studies in annotated databases and literature.  
We further integrate the relationship information in a large-scale graph, called the GPCR heterodimer 
network [60], where the vertices are the receptor protomers and the edges are their relationships. The 
results from the GPCR-HetNet indicate a scale-free model in which a few of the protomers dominate 
the connectivity and hold the network together. Three different hub criteria show that the dopamine D2 
receptor (DRD2), the beta-2 adrenergic receptor (ADRB2), the growth hormone secretagogue receptor 
type 1 (GHSR), the mu-type opioid receptor (OPRM), the delta-type opioid receptor (OPRD), the 
kappa-type opioid receptor (OPRK), the adenosine A2A receptor (AA2AR) and the adenosine A1 
receptor (AA1R) are the hubs in the network. Other highly connected protomers are also identified and 
described in this study, as well as the emergence of potential allosteric mechanism avenues and higher 
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order heteroreceptor complexes. In this study we present for the first time the overall architecture of 
the GPCR heteromers. The GPCR-HetNet provides insight into receptor–receptor interaction 
connectivity, topology, and organization that could be used to generate plausible hypotheses and help 
researchers to better understand GPCR heteromer systems and design experiments. 
2. Results and Discussion 
2.1. The GPCR-HetNet Dataset 
Scopus (http://www.scopus.com) and the Search Tool for the Retrieval of Interacting Genes 
(STRING: http://string-db.org/) databases were searched for experimentally validated interactions of 
GPCR heteromers, supported by at least one detection method (among others co-immunoprecipitation [17], 
bioluminescent and fluorescent energy transfer methods (Bioluminescence Resonance Energy Transfer 
(BRET), Fluorescence Resonance Energy Transfer (FRET), Sequential Resonance Energy Transfer 
(SRET), Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET), and the Bimolecular 
Fluorescence Complementation (BiFC) approach) [14,53], fluorescence cross-correlation spectroscopy 
(FCCS) [57,58] and in situ Proximity Ligation Assays (PLA) [12]). Each interaction was inspected 
twice to confirm the literature information. Experimentally verified physical receptor–receptor 
interactions were reported for 156 GPCR protomers (Table 1), which collectively account for 
approximately 20% of the total number of putative human GPCR protomers (a total number of 797 
human GPCRs exists in the UniProt database, as recently annotated and described by Jassal et al., 
2010 [61]). This percentage can be considered as a substantial sample of the GPCR population. 
Table 1. General properties of the receptor–receptor heteromer interaction network.  
F1, G-protein coupled receptor 1 (Class A or rhodopsin-like); F2, G protein-coupled 
receptor 2 (Class B or Secretin receptor family); F3, G protein-coupled receptor 3 (Class C 
or Metabotropic glutamate/pheromone). 
Number of receptor protomers per GPCR 
family that showed to form at least  
one heteromer 
Number of receptor interaction 
pairs/connectivity (intrafamily: F1, F2, F3  
and interfamily) 
F1 F2 F3 F1 F2 F3 Interfamily 
128 15 13 219 15 17 9 
According to the UniProt classification, we were able to retrieve 128 rhodopsin-like protomers 
(class A, also known as Family 1) representing 18%–25% of the total number of putative protomers in 
this superfamily (726 including orphan receptors and 519 true non-orphan receptors, respectively). 
Interaction data for the rhodopsin-like superfamily members, which included non-orphan and orphan 
receptors, were the most incomplete although they represent approximately 82% of the total number of 
identified protomers. In comparison, experimentally verified interactions were reported for 15 out of 
46 members of the Secretin-like superfamily members (class B, also known as Family 2) representing 
33% of the total number of putative protomers of this superfamily; and 13 out of 22 metabotropic 
Glutamate receptor-like superfamily members (class C, also known as Family 3) were involved in at least 
one interaction, representing 60% of the total number of putative protomers of this superfamily (Table 1). 
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The network was built taking into account only GPCR heteromers. We excluded homomer 
information although it can be important to mention that more than 87% of the total identified 
protomers exist as homomers as well. It must be underlined that it was recently demonstrated using 
fluorescence correlation spectroscopy with photon counting histogram analysis (a sensitive method for 
monitoring diffusion and oligomer size of plasma membrane proteins) that biogenic amine receptors 
freely diffusing within the plasma membrane are predominantly homodimers and not monomers [58]. 
The balance between homo- versus heteromer GPCR populations is an important factor to take into 
account based on the fact that it could be the molecular determinant behind some pathological diseases 
where the GPCR dimerization phenomenon plays a role. 
The analysis of receptor–receptor interaction (intrafamily and interfamily) connectivity reveals  
a significant dominance of intrafamily versus interfamily connections (Table 1). One mechanism  
that might explain such a marked difference could be a favourable co-evolution of the protomer 
interface interaction inside each subfamily. GPCRs have high sequence homologies/similarities inside 
each superfamily but reduced shared sequence homologies between them [62]. For example, the 
Secretin-like superfamily, one of the largest and best-studied hormone and neuropeptide receptor 
families, is suggested to have emerged from a single ancestral gene via duplication events. As a result, 
it shows a high sequence homology between its members [63]. It has been demonstrated that 
homologous proteins belonging to the same family can share similar interfaces where their exposed 
residues can be either intermixed or run in parallel to one another [64]. Also, their conserved domains 
or motifs can take part in domain swapping phenomena as shown for some GPCR heteromers [35,36,65]. 
A second reason could be the diversity/specificity in the cell and tissue expression pattern for some 
receptor clans. Some receptor classes are more widely expressed in some tissues or organs than others, 
and as a result allow their members to have a higher probability of encounters and interactions.  
A further reason that cannot be excluded is the lack of experimental data or analysis of GPCR 
interfamily heterodimerization. In the last decade few research groups have focused on the study  
of GPCR heterodimerization specificities, which may unravel a more widespread existence of  
cross-family heterodimerization; alternatively, it is possible that it will verify a substantial degree of 
intrafamily GPCR-GPCR specificities. 
2.2. Analysis of the GPCR-HetNet Architecture: Network Measures and Models 
The behaviour of the most complex biological systems emerges from the orchestrated activity of 
many components that interact between each other through pairwise or multiple connections. These 
components can be reduced to a series of nodes and edges that form a network or, in more formal 
mathematical language, a graph. Establishing the identity of the GPCR receptor–receptor interaction 
networks is not trivial but physical interactions and connection between GPCR protomers can easily be 
conceptualized using the node-edge nomenclature, where the edges do not have an assigned direction. 
In the GPCR-HetNet, where the edge represents a mutual protomer binding relationship, it follows that 
if protomer A binds to protomer B, then protomer B also binds to protomer A. But how can this 
network be characterized? Networks are typically evaluated at two levels: the topology, which 
describes the architecture of the graph, as well as the interactions within. Network topology plays a 
vital role in understanding and evaluating the network architecture and performance. Several of the 
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most important topological metrics include node degree distribution, clustering coefficient, and path 
length, which allow us to characterize different complex networks. Detailed descriptions of these 
metrics are listed in the Experimental section. 
As seen in Table 2 and Figure 1, the GPCR-HetNet is comprised of 156 nodes (protomers) and  
260 degrees (interactions). In the network, 44% of the protomers/nodes have three or more 
interactions. However, nine protomers/nodes have 10 or more connections: OPRM (17), DRD2 (17), 
ADRB2 (13), AA2AR (12), AA1R (11), OPRK (10), OPRD (10), GHSR (10) and 5HT1A (10). 
Together these nine highly connected protomers account for 42% of all links in the GPCR HetNet 
network. In the network the maximal distance between any two protomers (the graph diameter) was 
nine. A network with a small diameter is often termed a “small world architecture” network in which 
any two nodes can be connected with relatively short paths. This “small world architecture” effect 
observed in the GPCR-HetNet, has been detected in several biological systems. It also depends on 
other network properties like the clustering coefficient or the path length indicator. 
Table 2. GPCR HetNet topological metrics. 
Protomers/nodes Interactions/edges Density Diameter Average degree Clustering coefficient 
156 260 0.02 9 3.03 0.25 
Path length tells us how many edges we need to pass through to travel between two nodes and is  
a measure of the efficiency of information transfer in the network as well as the overall navigability. 
The path length distribution for the GPCR-HetNet is shown in Figure 2C. The mean path length is 3.9. 
Few path lengths fall into the extreme upper categories (path lengths 8 and 9) as compared to the lower 
extremes (path lengths 1 and 2), indicating that most of the receptors within the network can be linked 
to every other protomer by a small number of edges. Short paths are considered more desirable because 
they minimize transition times [66]. One drawback, however, is that they may be highly susceptible to 
local disturbances which can be transmitted throughout the network quickly. 
Based on experimental evidence, we introduced the concept of receptor mosaic (RM) [67]. The idea 
of RM suggests that receptors can form even more complex and dynamic receptor networks, with 
respect to time and receptor stoichiometry. Recently, trimeric RMs were described as mGlu5–D2–A2A 
receptors [68], as A2A–D2–CB1 receptors [69,70] and as 5-HT1A-GalR1-GalR2 [71]. They have the 
potential to make a significant contribution to the diversity and specificity of GPCR trafficking and 
signalling and have been implicated in multiple neurological and psychiatric disorders. In light of new 
indications from the GPCR-HetNet analysis, which shows that most of the receptors within the 
network can be linked to every other protomer by a small number of paths, it becomes clear that GPCR 
heteromers are available in an efficient manner to form higher order heteroreceptor complexes or RM 
(experimentally demonstrated [68]). 
The analysis of the degree of distribution and clustering coefficient approximates a power law that 
indicates a scale-free topology (Figure 2A,B and Table 3). The scale-free model of the GPCR-HetNet 
is apparent in Figure 1, where most protomers participate in only a small amount of interactions, but a 
few participate in dozens. The advantage of this type of organization is that the system is more robust 
and network properties are often determined by a relatively small number of highly connected 
protomers/nodes that are known as hubs. 
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Figure 1. GPCR HetNet graph. Color code: blue, Family 1 or Class A; red, Family 2 or 
Class B; orange, Family 3 or Class C. 
 
2.3. Hubs and Non-Hubs within the GPCR HetNet 
The topological analysis reveals that the GPCR-HetNet is not randomly organized but is rather of  
a “scale-free” format containing hubs with many connections and a large number of nodes that have 
one or a small number of connections. 
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Figure 2. Topological properties distributions. In (A) and (B) we present the node degree 
distribution and clustering coefficient distribution for the GPCR receptor–receptor interaction 
network, respectively. The network shows power-law node degree and clustering coefficient 
distributions (see Table 3 for further details). Axes are plotted on logarithmic scale.  
In (C) we show the path length distribution of the GPCR-HetNet. 
 
A B C 
Table 3. Network model comparison. R2 as metric of goodness of distribution fit. 
Node degree distribution Clustering coefficient distribution 
Linear Power-law Linear Power-law 
0.53 0.91 0.56 0.80 
We also now know, based on various proposed models aimed to explain the development of the 
scale-free topology of the protein–protein interaction network during evolution, that in such a particular 
architecture the probability that a newly added node interacts with an existing node is proportional to 
its connection degree. This leads to a so-called preferential attachment model in which rich nodes get 
richer during evolution and finally form a scale-free network [6,7]. In general, core components of a 
network tend to be conserved, whereas components at the periphery or false interactions are not. 
Therefore, hub components in a scale-free network are extremely important and hence usually play 
essential roles in biological systems versus lesser-connected nodes [6,72–74]. We can also state that 
the current identified hubs, because they are part of a “scale-free” network, can continuously exist as 
hubs independently of the evolution or growth of the network when new nodes (protomers) are 
identified and added in the feature. 
The hub designation itself, however, is somewhat arbitrary. For clarity, hubs are defined in this 
work following four different criteria including the more objective characterization of hubs described 
recently by Vallabhajosyula et al., 2009 [75] (see the Experimental Section and Table 5). As shown in 
Tables 4 and 5 and Figure 3, two of the hub definitions employed (the top 95% of the high degree node 
criterion [76] and a node degree higher than eight interaction criterion [77]) allow the identification of 
eight hubs (OPRM, DRD2, ADRB2, AA2AR, AA1R, OPRK, OPRD and GHSR) which belong to the  
rhodopsin-like class A GPCR subfamily. A more permissive criterion, where the node degree is higher 
than five interactions [72] results in the identification of 29 hubs, among which at least two hubs 
belong to the Class C GPCR subfamily (mGluR2 and mGluR5) and one to the Class B GPCR 
subfamily (SCTR). However, the relative connectivity criterion [75] in the GPCR-HetNet identified as 
a hub only the dopamine D2 receptor (DRD2), the beta-2 adrenergic receptor (ADRB2) and the  
mu-type opioid receptor (OPRM). When considering the less conservative criterion some, if not all of 
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these protomers, may eventually emerge as hubs in the evolution of the GPCR-HetNet when the 
interaction profiles expand. 
Table 4. No-hubs and hub selection criteria. 
No. hubs 
(degree = 1) 
Hub selection criteria 
Relative connectivity Top 95% of the high degree nodes Node degree > 5 Node degree > 8 
cutoff #hubs cutoff #hubs cutoff #hubs cutoff #hubs 
57 12 3 10 8 5 29 8 12 
Figure 3. Hubs identified according to different criteria (“top 95% of the high degree 
nodes” and “node degree > 8”) are shown in blue. 
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Table 5. Chosen non-hubs and hubs. 
Non-hubs 
5HT2B, 5HT2C, 5HT4R, AA3R, ACKR1, ACKR3, ADA1A, ADRB3, CALRL, CCKAR, CCR7, 
CD97, CLTR1, CLTR2, CNR2, CRFR1, EDNRA, EMR3, FPR2, FPR3, FSHR, GABR1, GALR2, 
GHRHR, GPR26, GPR55, GPR83, GRPR, HRH2, MAS, MCH1R, MRGRD, MRGRE, MRGX1, 
MSHR, NK1R, NPBW1, NPFF2, NPY1R, NPY4R, OX1R, PE2R1, PE2R3, PTH1R, PTH2R, RXFP1, 
RXFP2, SIPR4, S1PR5, SSR1, SSR4, TAAR1, TS1R1, TS1R2, TSHR, V1BR 
Hub selection criteria 
Relative connectivity Top 95% of the high degree nodes Node degree > 5 Node degree > 8 
DRD2 = 17,  
OPRM = 17,  
ADRB2 = 13 
DRD2 = 17,  
OPRM = 17,  
ADRB2 = 13,  
AA2AR = 12,  
AA1R = 11,  
OPRK = 10,  
OPRD = 10,  
GHSR = 10 
DRD2 = 17,  
OPRM = 17,  
ADRB2 = 13,  
AA2AR = 12,  
AA1R = 11,  
OPRK = 10,  
OPRD = 10,  
GHSR = 10,  
5HT1A = 10,  
S1PR3 = 9,  
S1PR1 = 9,  
CNR1 = 9,  
SCTR = 8,  
P2RY1 = 8,  
LPAR1 = 8,  
AGTR1 = 8,  
SSR5 = 7,  
P2RY2 = 7,  
LPAR3 = 7,  
LPAR2 =7,  
GRM2 = 7,  
GPR4 = 7,  
DRD1 = 7,  
S1PR2 = 6,  
P2Y12 = 6,  
OGR1 = 6,  
GRM5 = 6,  
CXCR4 = 6,  
CCR5 = 6 
DRD2 = 17,  
OPRM = 17,  
ADRB2 = 13,  
AA2AR = 12,  
AA1R = 11,  
OPRK = 10,  
OPRD = 10,  
GHSR = 10,  
5HT1A = 10,  
S1PR3 = 9,  
S1PR1 = 9,  
CNR1 = 9 
Previous work also indicated that the D2 receptor is a hub receptor in view of the existence of  
a large number of different types of D2 heteroreceptor complexes in the Central Nervous System 
(CNS) [14,78]. The Tarakanov and Fuxe hypothesis [79] states that protriplet homologies participate in 
recognizing the other receptor protomer of the heteromer via postulated “guide-and-clasp” interactions 
in the receptor interface [79–82]. As to the D2 receptor, the AVI protriplet homology may participate 
in receptor–receptor interactions of five D2 receptor heteromers: D1–D2, D2–GPR37, D2–5HT2A,  
D2–CCK2R and D2–NMDA. The DLL protriplet homology is present in six D2 receptor heteromers, 
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D1–D2, D2–D3, D2–D4, D2–CCK2R, CB1–D2 and D2–NTS1, but located in part in different types of 
D2 receptor heteromers compared with the AVI triplet [78]. Thus, the D2 receptor emerges as a hub 
receptor in the receptor networks of the CNS, which via allosteric receptor–receptor interactions in 
large numbers of D2 heteroreceptor complexes play a major integrative role. The impact of the D2 
receptor on information handling is also demonstrated by the fact that it is the major target for 
antipsychotic drugs [83]. 
2.4. Clustering and Modularity within the GPCR HetNet 
Visual inspection of the GPCR-HetNet (Figure 1) shows that rhodopsin-like receptors (blue), 
especially monoaminergic receptors, most generally occur in the dense regions of the graph. However, 
the rhodopsin-like members, sphingosine 1-phosphate receptors (S1P receptors) and lysophosphatidic 
acid receptors (LPA receptors) (top-right of the graph), are interacting with several GPCRs but are 
connected to the network by a relatively small number of links. Members of the metabotropic 
glutamate receptor family (orange) border the central area but are situated in less dense regions. The 
Secretin-like receptor family (red), despite being well connected and represented in this network with 
almost 60% of their members, does not have connectivity to the rest of the network. There are also 
several GPCRs (23 protomers) that are not connected to the main network at all. These are: TSHR, 
LSHR, FSHR, MTR1A, MTR1B, MTR1L, FPR2, FPR1, FPR3, CD97, EMR2, EMR3, TS1R2, 
TS1R3, TS1R1, CLTR1, CLTR2, CRFR1, V1BR, MRGRE, MRGRD, RXFP1, RXFP2. The lack of 
connectivity for these proteins may be due to the absence of experimental data. However, they may 
represent future branch points or subgraphs like, for example, the SCTR or MTR1A clusters (see 
Figure 4). As mentioned above, some receptors are less widely expressed in some tissues or organs 
than others, or have a more restricted tissue expression profile, and as a result allow their members to 
have a lower probability of encounters and interactions and therefore lower heterodimeric diversity. 
Receptor function is likely to be carried out in a highly modular manner, and GPCRs are not the 
exception. From the point of view of the GPCR-HetNet, modularity refers to a group of physically or 
functionally linked protomers (nodes) that work together to achieve a distinct function. In a network 
representation, a module (cluster) appears as a highly interconnected group of nodes that can be 
determined by the clustering coefficient, the signature of a network’s potential modularity.  
The clustering coefficient quantifies the number of connected pairs between a node and its neighbours 
and can be measured both globally (the average of the clustering coefficients for all the nodes in the 
entire network) and locally (the embeddedness of single nodes). It is important because it can provide 
insight into the overall organization of the relationships within a network (network hierarchical 
character). It may also indicate the presence of physical/functional modules which, in the case of 
receptor–receptor interaction network, can represent higher order heteroreceptor complexes or receptor 
mosaics. The global clustering coefficient of the GPCR-HetNet (the average of the clustering 
coefficients for all nodes in the network) is 0.25. Using a cluster search algorithm that considers  
highly interconnected dense regions within a network (MCODE) 10 clusters were identified in the  
GPCR-HetNet (Figure 4). Out of 156 total protomers in the network, 56 (36%) of these are located 
within clusters. 
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Figure 4. GPCR-HetNet motifs. Nine clusters identified using the MCODE search 
algorithms are represented and rank ordered, from top left to right down, according to their 
density (inter-connectivity) and size (number of protomers). 
 
3. Experimental Section 
3.1. GPCR Receptor–Receptor Interaction Dataset 
Interaction data for each of the individual human GPCR protomers were obtained manually from 
the Search Tool for the Retrieval of Interacting Genes [84] database and literature (SCOPUS database). 
Only protomers that have been validated by one (65%) or more (35%) independent publication 
(experimentally verified interactions) were used to create the graph. If we, in addition to the number of 
publication criteria, also consider the number of experimental methods used to validate each pair, the 
analysis of the 260 pairs revealed that more than 96% of them have been validated by more than one of 
the following experimental methods (co-immunoprecipitation, BRET/FRET/SRET/TR-FRET/BiFC,  
in situ PLA, and FCCS). Also, from the total of 260 pairs, only 15 pairs (5.78%) represent a 
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controversial issue. Looking carefully at the publications on this controversial approximately 6%, 3% 
do not represent a true controversy. For instance, the P2RY2/P2RY4 and P2RY2/P2RY6 are heteromer 
pairs that can interact in different cell types but do not interact in PC12 cells. The controversy does not 
rely on the interaction itself but on the type of cell in which it can take place. It is reasonable to think 
that depending on the tissue or cell type, many GPCR heteromers will show a different pattern of 
receptor–receptor interactions, dependent on the cell milieu. The second false controversy is the 
example of D2R-D4R, where the controversy arises from the receptor isoform studied. D2LR interacts 
with the main D4R isoforms but D2SR only interacts with some of them. Variability in the 
intracellular loops of GPCR, as a result of gene splicing, may play an important role in the selectivity 
and affinity of GPCR protomers. 
The dataset list and the references for each interaction are provided at GPCR-HetNet [60], 
containing 260 pairs of GPCR heteromers taken from a total of 156 unique GPCR protomers which 
represent approximately 20% of the total number of human GPCR protomers. This database will be 
updated as needed and relies on the continued support of the GPCR community. 
3.2. Network Construction and Analysis 
Networks have proven to be a useful mathematical artifact for studying complex systems in 
multiple disciplines such as economics, sociology, and biology [2,6,8,9]. The term biological network 
refers to networks that describe relationships among a set of elements within biological systems.  
A network can be formally defined by a set of N elements and a set of R relations among those 
elements. A graph is a common way of visualizing networks. In a network graph, the nodes of the 
graph are the elements of the network and the edges correspond to the relations among the elements of 
the network. The GPCR-HetNet can be considered as a network of interactions amongst GPCR 
protomers. Each protomer in a receptor complex is considered as a node in the network and the 
connections between the nodes are the edges. The interaction data were used to build and analyze the 
network using Cytoscape [85], a network visualization and analysis platform that supports a wide 
variety of plug-ins relative to network analysis and manipulation. Duplicated edges and self-loops 
resulting from reciprocal interaction detection (ex. homodimerization) were removed prior to the 
analysis. The network was treated as undirected throughout the study, meaning that there were no 
distinctions implied between the nodes. An undirected network or graph is a network where all the 
edges (the connection between nodes) are bidirectional. In contrast, a network where the edges point in 
a direction is called a directed network. It is worth mentioning that one network may be depicted by 
different graphs. This means that the same network can have different layouts or shapes, which, in 
turn, may lead to inconsistent interpretations depending on the chosen graph. In order to overcome this 
misinterpretation issue, many studies propose determining topological features of networks instead of 
analyzing their graphical representations [6,7,86]. A topological feature of a network is an invariant 
property whose value is the same no matter the network graph chosen. Cytoscape was used to calculate 
the basic network metrics such as the number of nodes and edges, density, diameter, degree 
distribution, path length, and clustering coefficient. Hubs were identified using four different criteria 
(see below for more details). 
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3.3. Topological Features 
The most elementary topological feature of a network is the node degreek, which measures  
the number of connections or links the node maintains with the other nodes. The node degree 
distribution of a network, P(k), is the fraction of nodes that have exactly k connections to other nodes, 
i.e., P(k) = degreek/N, where degreek is the number of nodes with degree equal to k. A path between  
a pair of nodes is a set of adjacent edges and nodes that we need to visit in order to travel from one 
node to the other. The path distance is the number of edges the path contains. The shortest path 
between a pair of nodes is the path that has the smallest path distance. A clustering coefficient assesses 
the trend of the nodes of the network to form clusters. The local clustering coefficient of node n is 
given by the following formulae: C(n) = 2nl/k (k − 1), where nl is the number of connections among 
the nodes that n is connected to. The clustering coefficient of a network is the average of the local 
clustering coefficients of all nodes in the network. The clustering coefficient distribution, C(k), is 
defined by the average of the clustering coefficient of the nodes with degree equal to k. The so-called 
network density D assesses how connected the network is, D = averagek/N − 1, where averagek is the 
average degree of the network. A connected component is a subgraph in which every pair of nodes is 
connected to each other by at least one path. Another feature of the topological connectivity of a 
network measures the relative size of the largest component of a network. This is computed by 
dividing the number of nodes in the largest component by the number of total nodes in the network. 
This measure is referred to as the relative connectivity, f (for further details see [6]). 
3.4. Network Models 
Knowing the model of our biological network is essential to further understand the complex system 
that is modeled. To this aim we need to examine two of the aforementioned topological features: node 
degree distribution, P(k), and clustering coefficient, C(k). Barabási et al. describe three models of 
biological networks labelled as: random, scale-free, and hierarchical [6]. In a random network, P(k) 
follows a Poisson distribution and C(k) is independent of the node degree k. In other words, the 
majority of nodes have roughly the same number of connections, and their tendency to form clusters  
is the same no matter the node degree. In contrast, node degrees show a power-law distribution,  
P(k)~k−γ, in scale-free and hierarchical models. In these models, networks have many nodes with small 
degrees and allow nodes with high degrees. The most notable characteristic of these two models is the 
so-called preferential attachment property, which implies that a newly added node is more likely to 
interact with nodes of higher degrees. Scale-free and hierarchical models, however, differ from each 
other in the way C(k) is expressed. Similar to random networks, C(k) is independent of k in scale-free 
networks. In contrast to scale-free networks, C(k) in hierarchical networks can be expressed as a 
function of the degree in the following way: k−1. Hierarchical networks can be seen as a special type of 
scale-free network with a large clustering coefficient. 
3.5. Hubs and Non-Hubs 
Preferential attachment property in scale-free and hierarchical models leads to the origin of hubs,  
a relatively small set of highly connected nodes. Several studies report that hubs have biological 
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significance in biological networks such as protein interaction networks [72–74]. However, despite its 
simple definition, there is no consensus on when a node is a hub. In Batada et al. the top 95% of the 
high degree nodes were selected as hubs [76]. Nodes with degrees greater than five and eight were 
defined as hubs in Han et al. [72] and Ekman et al. [77], respectively. Vallabhajosyula et al. [75] 
proposes an objective characterization of hubs, which relies on the idea that hubs have lower 
connectivity among themselves than non-hub nodes. The procedure for selecting hubs according to 
relative connectivity is as follows. First, we create a systematic list of the network nodes by the 
decreasing order of their degree. Secondly, we generate successive subgraphs adding, each time, one 
node from the degree list. For instance, we first generate G1, which consists of just one node: the one 
that appears at the front of the degree list. Then we add the second node from the list and generate 
subgraph G2, and so on. For each subgraph we compute its relative connectivity f. This process 
continues until we obtain a subgraph Gk whose relative connectivity fk is larger than fk−1. Value k is 
interpreted as the natural boundary between hub and non-hub nodes, and nodes from Gk−1 are the hubs 
of the network. In this paper we identify hubs following all these four selection criteria. 
3.6. Clusters and Motif 
Clusters were found with Molecular Complex Detection (MCODE) [87] using the haircut option 
which identifies nodes that have limited connectivity at the cluster periphery. A value of 2.0 was used 
for the degree of cutoff, representing the minimum number of edges for a node to be scored. The  
K-Core value, which is used to filter out clusters lacking a maximally interconnected core, was 
specified for two edges [66]. 
4. Conclusions 
The existence of GPCR heteromers was demonstrated through diverse methods [12,17,52–54].  
In this study, we manually collected static/non-dynamical human GPCR data derived from these 
interaction studies in annotated STRING and SCOPUS databases. We further integrated the 
relationship information in a large-scale graph, called the GPCR heteromer network [60], where the 
vertices are the receptor protomers and the edges are their relationships. The results for the  
GPCR-HetNet indicate a scale-free model in which a few of the protomers dominate the connectivity 
and hold the network together. Three different hub criteria show that the dopamine D2 receptor 
(DRD2), the beta-2 adrenergic receptor (ADRB2), the growth hormone secretagogue receptor type 1 
(GHSR), the mu-type opioid receptor (OPRM), the delta-type opioid receptor (OPRD), the kappa-type 
opioid receptor (OPRK), the adenosine A2A receptor (AA2AR) and the adenosine A1 receptor 
(AA1R) are the hubs in the network. Other highly connected protomers are also identified and 
described in this study, as well as the emergence of potential allosteric mechanism avenues and higher 
order heteroreceptor complexes. In this study we present for the first time the overall architecture of 
the GPCR heteromers. The GPCR-HetNet provides insight into receptor–receptor interaction 
connectivity, topology, and organization that could be used to generate plausible hypotheses and help 
researchers to better understand GPCR heteromer systems and design experiments. 
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